BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 623449)

  • 1. [Properties and stability of tetracycline hydrochloride tablets].
    Nesterova LIa; Donskaia NG; Shadyro LL; Grakovskaia LK
    Antibiotiki; 1978 Jan; 23(1):62-6. PubMed ID: 623449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality and stability of tetracycline tablets].
    Nesterova LIa; Grakovskaia LK; Shadyro LL; Okhotnikova VF
    Antibiotiki; 1980 Nov; 25(11):828-31. PubMed ID: 7447399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Properties of tetracycline hydrochloride tablets and their bioavailability].
    Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB
    Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Film-coated zinc sulphate tablets and the effect of humidity on tablet properties.
    Gürsoy A; Akbuğa J
    Pharmazie; 1986 Aug; 41(8):575-8. PubMed ID: 3786379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
    Zak AF; Ermolova OB
    Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of cyanocobalamin in sugar-coated tablets.
    Ohmori S; Kataoka M; Koyama H
    Int J Pharm; 2007 Jun; 337(1-2):161-8. PubMed ID: 17300886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):476-8. PubMed ID: 4767501
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and evaluation of the tablets coated with the novel formulation termed thin-layer sugarless coated tablets.
    Ohmori S; Ohno Y; Makino T; Kashihara T
    Int J Pharm; 2004 Jul; 278(2):459-69. PubMed ID: 15196649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
    Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
    Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric coating derived from marine sponge collagen.
    Nicklas M; Schatton W; Heinemann S; Hanke T; Kreuter J
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1384-8. PubMed ID: 19832639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of the physical stability of tablets prepared from powders stored under tropical conditions.
    York P
    Pharmazie; 1976 Jun; 31(6):383-6. PubMed ID: 959298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silk fibroin as a novel coating material for controlled release of theophylline.
    Bayraktar O; Malay O; Ozgarip Y; Batigün A
    Eur J Pharm Biopharm; 2005 Aug; 60(3):373-81. PubMed ID: 15996578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 1. Effect of binders.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1972 Sep; 27(9):600-3. PubMed ID: 5086358
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
    Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
    Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
    Thoma K; Oschmann R
    Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.